Abstract:ABSTRACT Microbial secondary metabolites play crucial ecological roles in governing species interactions and contributing to their defense strategies. Their unique structures and potent bioactivities have been key in discovering antibiotics and anticancer drugs. Genome sequencing has undoubtedly revealed that myxobacteria constitute a huge reservoir of secondary metabolites as the well-known producers, actinomycetes. However, because most secondary metabolites are not produced in the laboratory context, the natural products from myxobacteria characterized to date represent only the tip of the iceberg. By combining the engineering of a dedicated Myxococcus xanthus DZ2 chassis strain with a two-step growth medium protocol, we provide a new approach called two-step Protocol for Resource Integration and Maximization–Biomolecules Overproduction and Optimal Screening Therapeutics (2PRIM-BOOST) for the production of non-ribosomal peptides synthetases (NRPS)/polyketides synthases (PKS) secondary metabolites from myxobacteria. We further show that the 2PRIM-BOOST strategy will facilitate the screening of secondary metabolites for biological activities of medical interest. As proof of concept, using a constitutive strong promoter, the myxoprincomide from M. xanthus DZ2 has been efficiently produced and its biosynthesis has been enhanced using the 2PRIM-BOOST approach, allowing the identification of new features of myxoprincomide. This strategy should allow the chances to produce and discover new NRPS, PKS, and mixed NRPS/PKS hybrid natural metabolites that are currently considered as cryptic and are the most represented in myxobacteria. IMPORTANCE Microbial secondary metabolites are important in species interactions and are also a prolific source of drugs. Myxobacteria are ubiquitous soil-dwelling bacteria constituting a huge reservoir of secondary metabolites. However, because most of these molecules are not produced in the laboratory context, one can estimate that only one-tenth have been characterized to date. Here, we developed a new strategy called two-step Protocol for Resource Integration and Maximization–Biomolecules Overproduction and Optimal Screening Therapeutics (2PRIM-BOOST) that combines the engineering of a dedicated Myxococcus xanthus chassis strain together with growth medium optimization. By combining these strategies with the insertion of a constitutive promoter upstream the biosynthetic gene cluster (BGC), the production of myxoprincomide, a characterized low-produced secondary metabolite, was successfully and significantly increased. The 2PRIM-BOOST enriches the toolbox used to produce previously cryptic metabolites, unveil their ecological role, and provide new molecules of medical interest.

Identification of a secondary metabolism-responsive promoter by proteomics for over-production of natamycin in Streptomyces

Transcriptome-Based Identification of a Strong Promoter for Hyper-production of Natamycin in Streptomyces.

Systematic Identification Of A Panel Of Strong Constitutive Promoters From Streptomyces Albus

Identification and characterization of a strong constitutive promoter stnYp for activating biosynthetic genes and producing natural products in streptomyces

Identification of A Novel Streptomyces Chattanoogensis L10 and Enhancing Its Natamycin Production by Overexpressing Positive Regulator Scnrii

Development of a native-locus dual reporter system for the efficient screening of the hyper-production of natural products in Streptomyces

Transposon-based Identification of a Negative Regulator for the Antibiotic Hyper-Production in Streptomyces

Promoter Activation in Δhfq Mutants As an Efficient Tool for Specialized Metabolite Production Enabling Direct Bioactivity Testing.

A Novel Method to Screen Strong Constitutive Promoters in Escherichia coli and Serratia marcescens for Industrial Applications

Genome Mining and Homologous Comparison Strategy for Digging Exporters Contributing Self-Resistance in Natamycin-Producing Streptomyces Strains

Multiplexed Promoter Engineering for Improving Thaxtomin A Production in Heterologous Streptomyces Hosts.

A Simple and Effective Strategy for the Development of Robust Promoter-Centric Gene Expression Tools

Combining culture optimization and synthetic biology to improve production and detection of secondary metabolites in Myxococcus xanthus: application to myxoprincomide

Promoter screening and identification for metabolic regulation in Acremonium chrysogenum

Promoter engineering of natural product biosynthetic gene clusters in actinomycetes: concepts and applications

Sigma Factor WhiGch Positively Regulates Natamycin Production in Streptomyces Chattanoogensis L10

[ABC transporter SgnA/B promotes extracellular transport and efficient production of natamycin]

Identification of a novel promoter for driving antibiotic-resistant genes to reduce the metabolic burden during protein expression and effectively select multiple integrations in Pichia Pastoris

Multiple transporters are involved in natamycin efflux in Streptomyces chattanoogensis L10.

Droplet-Microfluidic-Based Promoter Engineering and Expression Fine-Tuning for Improved Erythromycin Production in Saccharopolyspora erythraea NRRL 23338

Exploiting A Precise Design Of Universal Synthetic Modular Regulatory Elements To Unlock The Microbial Natural Products In Streptomyces